Echocardiographic predictors of mortality in intermediate-risk pulmonary embolism.
Critical care
Pulmonary embolism
Risk assessment
Transthoracic echocardiography
Journal
Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
16
09
2021
accepted:
09
12
2021
pubmed:
22
1
2022
medline:
9
8
2022
entrez:
21
1
2022
Statut:
ppublish
Résumé
Data regarding further risk stratification of intermediate-risk pulmonary embolism (IR-PE) are scanty. Whether transthoracic echocardiography may be helpful in further risk assessment of death in such population has still to be proven. Two-hundred fifty-four consecutive patients (51.6% females, age 63.7 ± 17.3 years) with IR-PE admitted to a tertiary regional referral center were enrolled. Patients underwent a complete transthoracic echocardiography within 36 h from hospital admission, on top of clinical assessment, physical examination, computer tomography pulmonary angiography (CTPA), and serum measurement of Troponin I (TnI) levels. The occurrence of 90 day mortality was chosen as primary outcome measure. When compared to survivors, non-surviving IR-PE patients had smaller left-ventricular end-diastolic volumes (39.8 ± 20.9 vs 49.4 ± 19.9 ml/m
Identifiants
pubmed: 35059990
doi: 10.1007/s11739-021-02910-w
pii: 10.1007/s11739-021-02910-w
doi:
Substances chimiques
Troponin I
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1287-1299Subventions
Organisme : Ministero della Salute
ID : GR-2016-02364727
Informations de copyright
© 2021. The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI).
Références
Raskob GE, Angchaisuksiri P, Blanco AN et al (2014) Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 34:2363–2371. https://doi.org/10.1111/jth.12698
doi: 10.1111/jth.12698
pubmed: 25304324
Oger E (2000) Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d’etude de la thrombose de bretagne occidentale. Thromb Haemost 83:657–660
doi: 10.1055/s-0037-1613887
Bĕlohlávek J, Dytrych V, Linhart A (2013) Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol 18:129–138
pubmed: 23940438
pmcid: 3718593
Stein PD, Henry JW (1995) Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 108:978–981. https://doi.org/10.1378/chest.108.4.978
doi: 10.1378/chest.108.4.978
pubmed: 7555172
Konstantinides S, Geibel A, Heusel G et al (2002) Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347:1143–1150. https://doi.org/10.1056/NEJMoa021274
doi: 10.1056/NEJMoa021274
pubmed: 12374874
Kline JA, Nordenholz KE, Courtney DM et al (2014) Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost 12:459–468. https://doi.org/10.1111/jth.12521
doi: 10.1111/jth.12521
pubmed: 24484241
Meyer G, Vicaut E, Danays T et al (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370:1402–1411. https://doi.org/10.1056/NEJMoa1302097
doi: 10.1056/NEJMoa1302097
pubmed: 24716681
Hao Q, Dong BR, Yue J et al (2018) Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004437.pub5
doi: 10.1002/14651858.CD004437.pub5
pubmed: 30560579
pmcid: 6516871
Konstantinides SV, Meyer G (2019) The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 40:3453–3455. https://doi.org/10.1093/eurheartj/ehz726
doi: 10.1093/eurheartj/ehz726
pubmed: 31697840
Ferrara F, Gargani L, Ostenfeld E et al (2017) Imaging the right heart pulmonary circulation unit: insights from advanced ultrasound techniques. Echocardiography 34:1216–1231. https://doi.org/10.1111/echo.13594
doi: 10.1111/echo.13594
pubmed: 28664665
Giri J, Sista AK, Weinberg I et al (2019) Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American heart association. Circulation 140:e774–e801. https://doi.org/10.1161/CIR.0000000000000707
doi: 10.1161/CIR.0000000000000707
pubmed: 31585051
Coutance G, Cauderlier E, Ehtisham J et al (2011) The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Crit Care. https://doi.org/10.1186/cc10119
doi: 10.1186/cc10119
pubmed: 21443777
pmcid: 3219376
Keller K, Coldewey M, Geyer M et al (2016) Shock index for outcome and risk stratification in acute pulmonary embolism✩. Artery Res 15:30. https://doi.org/10.1016/j.artres.2016.05.002
doi: 10.1016/j.artres.2016.05.002
Adams DM, Stevens SM, Woller SC et al (2013) Adherence to PIOPED II investigators’ recommendations for computed tomography pulmonary angiography. Am J Med 126:36–42. https://doi.org/10.1016/j.amjmed.2012.05.028
doi: 10.1016/j.amjmed.2012.05.028
pubmed: 23177546
Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 28:1-39.e14. https://doi.org/10.1016/j.echo.2014.10.003
doi: 10.1016/j.echo.2014.10.003
pubmed: 25559473
Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and cox regression. Am J Epidemiol 165:710–718. https://doi.org/10.1093/aje/kwk052
doi: 10.1093/aje/kwk052
pubmed: 17182981
Goldhaber SZ, Come PC, Lee RT et al (1993) Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341:507–511. https://doi.org/10.1016/0140-6736(93)90274-K
doi: 10.1016/0140-6736(93)90274-K
pubmed: 8094768
Grifoni S, Vanni S, Magazzini S et al (2006) Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events. Arch Intern Med 166:2151. https://doi.org/10.1001/archinte.166.19.2151
doi: 10.1001/archinte.166.19.2151
pubmed: 17060547
Fasullo S, Scalzo S, Maringhini G et al (2011) Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. Am J Med Sci 341:33–39. https://doi.org/10.1097/MAJ.0b013e3181f1fc3e
doi: 10.1097/MAJ.0b013e3181f1fc3e
pubmed: 20890176
Mitchell C, Rahko PS, Blauwet LA et al (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the american society of echocardiography. J Am Soc Echocardiogr 32:1–64. https://doi.org/10.1016/j.echo.2018.06.004
doi: 10.1016/j.echo.2018.06.004
pubmed: 30282592
Chow V, Ng ACC, Chung T et al (2013) Right atrial to left atrial area ratio on early echocardiography predicts long-term survival after acute pulmonary embolism. Cardiovasc Ultrasound 11:17. https://doi.org/10.1186/1476-7120-11-17
doi: 10.1186/1476-7120-11-17
pubmed: 23725312
pmcid: 3673888
Lobo JL, García Fuertes JA, Rivas A et al (2012) Right atrial enlargement and prognosis in the hemodinamically stable pulmonary embolism. Eur Respir J 40:2827
Tello K, Wan J, Dalmer A et al (2019) Validation of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio for the assessment of right ventricular-arterial coupling in severe pulmonary hypertension. Circ Cardiovasc Imaging. https://doi.org/10.1161/CIRCIMAGING.119.009047
doi: 10.1161/CIRCIMAGING.119.009047
pubmed: 31718275
pmcid: 7099862
Guazzi M (2018) Use of TAPSE/PASP ratio in pulmonary arterial hypertension: an easy shortcut in a congested road. Int J Cardiol 266:242–244. https://doi.org/10.1016/j.ijcard.2018.04.053
doi: 10.1016/j.ijcard.2018.04.053
pubmed: 29887455
Vonk Noordegraaf A, Westerhof BE, Westerhof N (2017) The relationship between the right ventricle and its load in pulmonary hypertension. J Am Coll Cardiol 69:236–243. https://doi.org/10.1016/j.jacc.2016.10.047
doi: 10.1016/j.jacc.2016.10.047
pubmed: 28081831
Sano M, Minamino T, Toko H et al (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446:444–448. https://doi.org/10.1038/nature05602
doi: 10.1038/nature05602
pubmed: 17334357
Walker CM, Chung JH, Reddy GP (2012) Septal bounce J Thorac Imaging. Jan;27(1):W1. https://doi.org/10.1097/RTI.0b013e31823fdfbd PMID: 22189246
Lyhne MD, Kabrhel C, Giordano N et al (2021) The echocardiographic ratio tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure predicts short-term adverse outcomes in acute pulmonary embolism. Eur Hear J - Cardiovasc Imaging 22:285–294. https://doi.org/10.1093/ehjci/jeaa243
doi: 10.1093/ehjci/jeaa243
Blanco P (2020) Rationale for using the velocity–time integral and the minute distance for assessing the stroke volume and cardiac output in point-of-care settings. Ultrasound J 12:21. https://doi.org/10.1186/s13089-020-00170-x
doi: 10.1186/s13089-020-00170-x
pubmed: 32318842
pmcid: 7174466
Trip P, Rain S, Handoko ML et al (2015) Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension. Eur Respir J 45:1603–1612. https://doi.org/10.1183/09031936.00156714
doi: 10.1183/09031936.00156714
pubmed: 25882798
Hobohm L, Hellenkamp K, Hasenfuß G et al (2016) Comparison of risk assessment strategies for not-high-risk pulmonary embolism. Eur Respir J 47:1170–1178. https://doi.org/10.1183/13993003.01605-2015
doi: 10.1183/13993003.01605-2015
pubmed: 26743479
Fernández C, Bova C, Sanchez O et al (2015) Validation of a model for identification of patients at intermediate to high risk for complications associated with acute symptomatic pulmonary embolism. Chest 148:211–218. https://doi.org/10.1378/chest.14-2551
doi: 10.1378/chest.14-2551
pubmed: 25633724
ten Wolde M, Söhne M, Quak E et al (2004) Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Intern Med 164:1685–1689. https://doi.org/10.1001/archinte.164.15.1685
doi: 10.1001/archinte.164.15.1685
pubmed: 15302640
Frémont B, Pacouret G, Jacobi D et al (2008) Prognostic value of echocardiographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1,416 patients. Chest 133:358–362. https://doi.org/10.1378/chest.07-1231
doi: 10.1378/chest.07-1231
pubmed: 17951624
Steering Committee 2012. Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Am Heart J. Jan;163(1):33-38.e1. https://doi.org/10.1016/j.ahj.2011.10.003 PMID: 22172434
doi: 10.1016/J.AHJ.2011.10.003
Prosperi-Porta G, Solverson K, Fine N et al (2020) Echocardiography-derived stroke volume index is associated with adverse in-hospital outcomes in intermediate-risk acute pulmonary embolism: a retrospective cohort study. Chest. https://doi.org/10.1016/j.chest.2020.02.066
doi: 10.1016/j.chest.2020.02.066
pubmed: 32243942
Kurnicka K, Lichodziejewska B, Goliszek S et al (2016) Echocardiographic pattern of acute pulmonary embolism: analysis of 511 consecutive patients. J Am Soc Echocardiogr 29:907–913. https://doi.org/10.1016/j.echo.2016.05.016
doi: 10.1016/j.echo.2016.05.016
pubmed: 27427291
Sanchez O, Trinquart L, Colombet I et al (2008) Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J 29:1569–1577. https://doi.org/10.1093/eurheartj/ehn208
doi: 10.1093/eurheartj/ehn208
pubmed: 18495689
Van Wolferen SA, Van De Veerdonk MC, Mauritz GJ et al (2011) Clinically significant change in stroke volume in pulmonary hypertension. Chest 139:1003–1009. https://doi.org/10.1378/chest.10-1066
doi: 10.1378/chest.10-1066
pubmed: 20864614
Van De Veerdonk MC, Kind T, Marcus JT et al (2011) Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 58:2511–2519. https://doi.org/10.1016/j.jacc.2011.06.068
doi: 10.1016/j.jacc.2011.06.068
pubmed: 22133851
Barco S, Russo M, Vicaut E et al (2019) Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the pulmonary embolism Thrombolysis (PEITHO) trial. Clin Res Cardiol 108:772–778. https://doi.org/10.1007/s00392-018-1405-1
doi: 10.1007/s00392-018-1405-1
pubmed: 30564950
Romiti GF, Recchia F, Zito A et al (2020) Sex and gender-related issues in heart failure. Heart Fail Clin 16:121–130. https://doi.org/10.1016/j.hfc.2019.08.005
doi: 10.1016/j.hfc.2019.08.005
pubmed: 31735310
Buratti L, Rocchi C, Totaro V et al (2021) Sex-related differences in polygraphic parameters in a population of patients with obstructive sleep apnea syndrome. CNS Neurol Disord - Drug Targets. https://doi.org/10.2174/1871527320666211022104140
doi: 10.2174/1871527320666211022104140